https://www.biopharmaapac.com/news/120/1356/novavax-announces-launch-of-global-vaccine-education-programs.html 2022-03-11T05:47:50+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1343/-lonza-leads-market-with-large-and-hla-typed-cd34-cell-lots-for-efficient-humanized-mouse-model-development.html 2022-03-08T04:58:29+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1333/biocon-biologics-to-acquire-viatris-biosimilar-assets-for-up-to-us3-335-billion-in-cash-and-equity.html 2022-03-03T09:16:50+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1315/moderna-and-thermo-fisher-scientific-announce-long-term-strategic-collaboration.html 2022-02-25T13:08:14+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1297/thermo-fisher-scientific-launches-new-portfolio-of-chromatography-and-mass-spectrometry-consumables.html 2022-02-21T19:57:58+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1266/-thermo-fisher-scientific-expands-applied-biosystems-portfolio.html 2022-02-10T09:20:12+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1256/mrna-covid-19-vaccines-are-safe-for-people-with-cancer-according-to-new-study-in-jnccn.html 2022-02-08T08:36:22+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1239/cas-launches-major-biology-expansion.html 2022-02-02T09:06:42+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1234/novavax-submits-request-to-the-u-s-fda-for-eua-of-covid-19-vaccine.html 2022-02-01T09:42:11+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1225/haemalogix-and-lonza-collaborate-to-manufacture-kappamab.html 2022-01-28T09:20:56+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1216/eppendorf-expands-its-portfolio-to-address-customers-separation-needs.html 2022-01-26T11:17:17+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1214/ahf-praises-merck-for-generics-urges-same-from-vaccine-makers.html 2022-01-25T09:18:00+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1203/nmn-supplement-a-promising-anti-aging-product-or-still-an-encouraging-lab-experiment-with-ongoing-clinical-trials.html 2022-01-23T21:30:35+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1183/waters-accelerates-quantitative-mass-spectrometry-with-new-application-on-waters-connect-informatics-platform.html 2022-01-17T09:34:41+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1181/gaumard-scientific-to-unveil-the-worlds-most-advanced-multidisciplinary-patient-simulator-hal-s530.html 2022-01-17T09:17:38+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1165/illumina-collaborates-with-nashville-biosciences-to-accelerate-medicines-development.html 2022-01-11T09:09:24+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1140/alamar-biosciences-partners-with-abcam-to-drive-understanding-of-the-human-proteome.html 2022-01-05T08:36:47+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1138/5-ways-to-help-reduce-the-risk-of-birth-defects.html 2022-01-04T08:31:56+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1137/worlds-first-automated-24-7-blood-pressure-monitor-comes-to-the-usa.html 2022-01-04T08:29:35+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1133/ionis-and-astrazeneca-close-deal-to-develop-and-commercialize-eplontersen.html 2022-01-03T09:19:44+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1099/who-sage-issues-interim-recommendations-for-novavax-covid-19-vaccine.html 2021-12-22T09:33:34+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1056/who-supports-use-of-johnson-johnson-covid-19-vaccine-as-a-booster.html 2021-12-10T09:22:09+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1050/thermo-fisher-scientific-completes-acquisition-of-ppd-inc-.html 2021-12-09T10:26:09+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/1026/bd-acquires-venclose-inc-to-extend-treatment-innovations-in-chronic-venous-disease.html 2021-12-03T13:29:01+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/927/novavax-files-covid-19-vaccine-for-eu-listing-with-who.html 2021-11-05T10:24:43+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/916/new-discovery-banana-beats-insomnia-and-anti-anxiety-approved-by-the-us-fda.html 2021-11-02T09:19:58+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/912/two-leaders-in-science-combine-complementary-best-in-class-technologies-for-biologics-manufacturing-customers.html 2021-11-01T09:17:11+05:30 monthly 0.8 https://www.biopharmaapac.com/opinion/120/909/why-is-the-who-delaying-an-eul-status-to-covaxin.html 2021-10-30T17:41:46+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/900/abcam-completes-340m-strategic-acquisition-of-biovision.html 2021-10-28T08:30:18+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/889/hummingbird-bioscience-collaborates-with-merck-for-a-clinical-trial-on-hmbd-002-our-anti-vista-antibody-in-combination-with-keytruda.html 2021-10-26T09:07:31+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/877/qiagen-launches-novel-qiareach-quantiferon-tb-tuberculosis-test-for-high-burden-regions.html 2021-10-21T09:12:42+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/872/thermo-fisher-scientific-prices-offering-of-usd-denominated-senior-notes.html 2021-10-20T09:15:51+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/869/phillips-medisize-increases-global-manufacturing-capacity.html 2021-10-20T09:08:27+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/860/merck-and-eisai-receive-positive-eu-chmp-opinions.html 2021-10-18T08:22:53+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/849/more-than-50-companies-modernize-pharmacovigilance-with-veeva-vault-safety-suite.html 2021-10-14T09:21:47+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/843/merck-completes-new-viral-vector-contract-development-manufacturing-facility-for-gene-therapy.html 2021-10-13T09:17:46+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/831/elixirgen-therapeutics-announces-licensing-agreement-for-its-novel-covid-19-vaccine.html 2021-10-11T09:22:17+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/828/fda-issues-final-order-and-guidance-on-surgical-staplers-and-staples-for-internal-use.html 2021-10-08T10:32:40+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/816/new-research-demonstrates-thymosin-beta-4s-potential-positive-effects-on-alzheimers-disease.html 2021-10-06T05:30:47+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/803/improve-covid-19-immunization-coverage-of-elderly-population.html 2021-10-01T19:31:31+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/801/sanofi-consumer-healthcare-expands-mental-health-pillar.html 2021-10-01T09:09:01+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/796/leadership-changes-at-merck-group-level-to-further-support-accelerated-growth.html 2021-09-30T00:40:07+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/790/veeva-announces-new-application-to-optimize-quality-control-labs.html 2021-09-29T08:52:01+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/787/foresees-the-future-trend-of-laboratory-technology.html 2021-09-28T08:45:30+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/784/avantor-partnership-will-broaden-global-access-for-scientists.html 2021-09-28T01:54:19+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/781/genscript-probio-and-askgene-enter-into-a-non-exclusive-license-of-a-sdab-targeting-immune-checkpoint-target.html 2021-09-27T08:36:51+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/780/novavax-and-serum-announce-submission-to-who-for-eu-listing-of-novavax.html 2021-09-24T09:28:46+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/776/ge-healthcare-to-acquire-ultrasound-innovator-bk-medical-boost-its-precision-health-presence.html 2021-09-23T23:26:52+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/775/thermo-fisher-scientific-launch-worlds-first-net-zero-mass-spectrometer.html 2021-09-23T18:57:36+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/774/orbit-health-secures-additional-funding-to-mature-digital-health-lab-.html 2021-09-23T16:46:31+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/771/thermo-fisher-scientific-advances-scalable-gene-therapy-workflows.html 2021-09-23T11:08:27+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/768/samsung-biologics-introduced-its-cdo-process-platform-s-celleratetm-at-bpi-2021.html 2021-09-23T09:29:20+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/765/bd-completes-study-investigating-performance-of-glass-prefillable-syringes-pfs-in-deep-cold-storage.html 2021-09-22T12:36:07+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/761/urotronic-inc-announces-completion-of-the-first-optilumer-procedure-in-asia.html 2021-09-22T09:16:35+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/755/zeiss-at-the-forefront-of-ophthalmology-with-new-data-management-innovations.html 2021-09-21T09:17:45+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/753/experts-call-on-world-leaders-to-commit-to-a-global-plan-of-attack-on-covid-at-summit.html 2021-09-21T09:12:00+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/744/satisfai-health-acquires-global-license-for-ai-software-to-detect-early-cancer-in-barretts-esophagus.html 2021-09-17T09:20:26+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/740/emmes-standardizes-on-veeva-development-cloud-to-streamline-product-development.html 2021-09-16T18:58:54+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/735/agilent-announces-thought-leader-award-to-david-r-liu-at-the-broad-institute.html 2021-09-15T20:37:04+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/730/everest-medicines-to-advance-mrna-vaccines-in-emerging-markets-in-asia-.html 2021-09-15T08:07:07+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/718/merck-to-present-latest-highlights-from-oncology-portfolio-at-wclc-and-esmo-2021.html 2021-09-13T09:12:22+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/717/novavax-launches-ph-1-2-clinical-trial-of-combined-covid-19-and-seasonal-influenza-vaccine.html 2021-09-11T10:34:51+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/715/-thermo-fisher-scientific-to-further-expand-global-network-of-single-use-technology-manufacturing-sites.html 2021-09-10T08:33:27+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/709/illumina-partners-with-merck-to-advance-cancer-diagnostics-and-precision-medicine-.html 2021-09-08T13:32:59+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/708/-avantor-buy-masterflex-bioprocessing-for-2-9-billion-from-antylia-scientific.html 2021-09-08T11:33:03+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/706/who-south-east-asia-countries-resolve-to-reorient-and-strengthen-health-system.html 2021-09-08T11:25:22+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/704/covid-19-threat-to-kidneys-drives-education-program-by-kidney-patients-and-doctors.html 2021-09-08T09:06:51+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/703/rmg-kb-bioaccess-fund-launches-with-worldwide-focus-on-innovative-life-sciences-ventures.html 2021-09-08T09:04:18+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/697/nuprobe-enables-rapid-ultrasensitive-mutation-detection.html 2021-09-07T08:57:01+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/692/moderna-announces-submission-of-data-to-european-medicines-agency-for-its-covid-19-vaccine-booster.html 2021-09-06T08:28:20+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/691/dr-reddys-lab-to-sell-its-rights-to-anti-cancer-agent-e7777.html 2021-09-06T08:25:46+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/682/-thermo-fisher-scientific-and-astrazeneca-to-co-develop-ngs-based-companion-diagnostics.html 2021-09-02T22:00:49+05:30 monthly 0.8 https://www.biopharmaapac.com/news/120/7444/novartis-secures-worldwide-licence-to-peplib-peptide-asset-to-expand-radioligand-therapy-pipeline.html 2026-01-14T14:05:26+05:30 monthly 0.8